Related Experiment Video
Updated: Dec 2, 2025

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Pre- and Postgastrostomy Evaluation of Gastroesophageal Reflux in Children Using 24-Hour pH Monitoring
Fatma Demirbaş1, Berat Dilek Demirel2, Gönül Çaltepe1
1Department of Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.
Insights
Gastrostomy feeding improved weight and BMI z-scores in neurologically impaired children. Concurrent Nissen fundoplication (NF) significantly reduced reflux, suggesting gastrostomy is safe and effective for enteral feeding.
Area of Science:
- Pediatric Surgery
- Gastroenterology
- Nutritional Support
Background:
- Neurologically impaired (NI) children often require enteral feeding due to dysphagia.
- Gastrostomy and concurrent Nissen fundoplication (NF) are surgical options for nutritional support and reflux management in this population.
- Evaluating the impact of these procedures on nutritional status and gastroesophageal reflux is crucial.
Purpose of the Study:
- To assess 24-hour pH monitoring results before and after gastrostomy in NI children.
- To compare outcomes between children who underwent gastrostomy alone versus those who had gastrostomy combined with NF.
- To evaluate changes in weight, BMI z-scores, and reflux indices post-procedure.
Main Methods:
- A prospective study involving 20 NI children undergoing gastrostomy (Group 1) or gastrostomy + NF (Group 2).
- 24-hour esophageal pH monitoring was performed pre- and postoperatively.
- Weight, BMI z-scores, and reflux indices were analyzed and compared between groups.
Main Results:
- Both groups showed significant improvements in weight and BMI z-scores post-procedure.
- Group 1 (gastrostomy alone) showed a non-significant trend towards increased pH index (P=0.061) and a significant increase in total bolus exposure (P=0.041).
- Group 2 (gastrostomy + NF) demonstrated a significant reduction in pH index (P<0.001) and total bolus exposure (P<0.001), indicating effective reflux control.
Conclusions:
- Gastrostomy feeding is an effective and safe method for enteral nutrition in NI children.
- Concurrent NF with gastrostomy significantly improves reflux control.
- The decision for concurrent NF should be individualized based on patient-specific needs and reflux severity.
Abstract:
The aim of this study was to evaluate 24-hour pH monitoring results before and after gastrostomy in neurological impaired (NI) children who underwent gastrostomy or Nissen fundoplication (NF) concurrently with gastrostomy. Between March and December 2018, NI patients who had previously received pre- and postgastrostomy (Group 1) or gastrostomy + NF (Group 2) underwent pH monitoring pre- and postoperatively. Twenty patients [12 males (60%) and the median age of 5.6 (14 months-14.7 years) years] with NI were followed up during the study period. When pre- and postgastrostomy weight and BMI z-scores were compared, the results were significantly higher in both groups after procedure (P = .043, P = .040, respectively). The clinical results of the patients after the operation showed improvement in both groups. The pH index of Group 1 (n = 11) was 2.32 (0-3.8) before gastrostomy and 3.18 (2.1-6.9) after gastrostomy (P = .061) and in Group 2 (n = 9) it was 5.85 (4.9-15.8) and 0.61 (0.3-1.3), before and after procedure (P < .001). There was a statistically significant difference in reflux index of each group. This difference was not statistically significant between the groups (P = .072). When the total bolus exposure index was compared, it was 4.01 (2.1-5.2) before gastrostomy and 5.67 (4.6-6.3) after gastrostomy in Group 1 (P = .041). In group 2, that index was found to be 9.8 (8.3-10.2) before and 1.28 (0.5-1.4) after (P < .001). There was a statistically significant difference in index after gastrostomy in Groups 1 and 2 (P = .023). Gastrostomy feeding is an effective and safe option to achieve enteral feeding in NI children. NF concurrent with gastrostomy should be decided according to the individual patient. Clinical trials protocol registration ID number was PRS NCT00445112.
Related Concept Videos
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Upper GI Series: Barium Swallow
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Assessment of the Gastrointestinal System I: Subjective Data
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...

